Watch Ticker

ABBVIE INC.

Go to ABBVIE INC. Website

$194.90

5.88 (3.11%)

Live

Previous Close

$195.22

Day Range

$189.785 - $197.06

Previous Day Range

$187.62 - $198.8256

Market Cap

$344.8 billion USD

Day Vol.

8.1 million

Previous Day Vol.

10.3 million

Currency

USD

Primary Exchange

New York Stock Exchange

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion

AbbVie reported Q2 sales of $15.42 billion, beating estimates with a 6.6% increase. The company raised fiscal 2025 earnings guidance and showed strong performance from Skyrizi and Rinvoq products, offsetting Humira's market erosion.

Related tickers: ABBV.

Read Full Article

Anthony Noto - Deal Dispatch: MEG Bidding War Heats Up, L Catterton Takes Bite Out Of Kisshokichi, Sunnova's Still Shining

Multiple M&A activities across various sectors including energy, technology, and restaurant industries, with notable deals involving MEG Energy, Baker Hughes, Sunnova Energy, and AbbVie.

Related tickers: CVE, CVE.WS, BKR, NOVAQ, ABBV.

Read Full Article

Trending Tickers

Please sign in to view